Barnik Invest Group Bolagizes Joint Venture with DynalisPharma, Creating BoniPharmex AB
Stockholm, Sweden – Barnik Invest Group today announced the bolagization of its joint venture project with DynalisPharma, resulting in the formation of BoniPharmex AB. This strategic move solidifies the partnership and positions BoniPharmex for significant growth in the market for probiotics and dietary supplements BoniPharmex was initially founded in 2021 as a joint venture between […]
Barnik Invest Group Announces the Formation of Barnik Holdings AB
Stockholm, Sweden – Barnik Invest Group, an investment firm dedicated to pioneering the advancement of innovative life science companies in the Nordics, today announced the formation of Barnik Holdings AB. This new holding company will serve as the umbrella entity for all Barnik Invest Group portfolio companies. Barnik Holdings AB will offer investors the opportunity […]
Barnik Invest Group Appoints Dr. Benedict Broennimann as Chief Scientific Officer
Stockholm, Sweden – Barnik Invest Group, today announced the appointment of Dr. Benedict Broennimann as Chief Scientific Officer. Dr. Broennimann is a highly accomplished medical and business executive with over 20 years of experience in the Life sciences industry. His extensive expertise and leadership will be invaluable as Barnik Invest Group continues to identify and […]
Barnik Invest Group to Showcase Portfolio Companies at Arab Health 2025
Stockholm, Sweden – Barnik Invest Group, today announced its participation in the 50th edition of Arab Health, taking place at the Dubai World Trade Centre from January 27-30, 2025. Barnik Invest Group will showcase its diverse portfolio of innovative companies at the event. Visitors to the Barnik Invest Group booth will have the opportunity to […]
Barnik Invest Acquires Idogen’s Technology Platform to Advance Immunotherapy
Stockholm, Sweden – Barnik Invest Group today announced the acquisition of Idogen AB’s technology platform. This strategic move positions Barnik Invest to lead the development of innovative therapies based on antigen-specific dendritic cell-mediated tolerance. The acquired technology platform holds immense potential to treat autoimmune diseases by modulating the immune system to target specific antigens. By […]
Barnik Invest Group Announces Joint Venture Partnership with Dynalis Pharma
Stockholm, Sweden – Barnik Invest Group, today announced a joint venture partnership with Dynalis Pharma, a renowned Swiss pharmaceutical company, to establish BoniPharmex. This strategic collaboration aims to leverage the combined expertise of both companies to develop and commercialize innovative probiotic and food supplement products. The company will leverage the expertise of both Dynalis Pharma […]
Barnik Invest Invests in Milmed Unico AB
Stockholm, Sweden – Barnik Invest Group today announced an investment in Milmed Unico AB. Milmed is developing a novel therapeutic approach based on a unique yeast culture with demonstrated potential in treating various health conditions. Milmed’s technology platform is built upon years of rigorous research, including pre-clinical studies conducted at Uppsala University and Sapienza University […]
Barnik Invest Group Acquires Sanikma AB and Rebrands as StartUpPharma Int. AB
Stockholm, Sweden – Barnik Invest Group today announced the acquisition of Sanikma AB and the rebranding of the company to StartUpPharma Int. AB. This strategic move strengthens StartUpPharmas position in the life sciences industry with its market access capabilities in the food supplement, pharmaceutical, biotech, and medical device sectors. StartUpPharma Int. AB is dedicated to […]
Barnik Invest AB Invests in Bonimedics.com to Shape the Future of MedicalAesthetics and Food Supplements E-commerce
Stockholm, Sweden – Barnik Invest AB, today announced a strategic investment in Bonimedics.com, to build a pioneering e-commerce platform poised to become a market leader in the medical aesthetics and food supplements market. This investment is made within StartUpPharma, a wholly-owned subsidiary of Barnik Invest AB focused on facilitating market access for life science companies. […]
Barnik Invest Invests in CathPrint AB, Enabling Advanced Catheter Technology
Stockholm, Sweden – Barnik Invest Group today announced an investment in CathPrint AB, a pioneering company developing innovative technologies for advanced catheter design. CathPrint’s groundbreaking “e-shaft” technology revolutionizes catheter manufacturing by enabling the integration of electronics directly onto the catheter shaft. This innovative approach offers significant advantages over traditional methods, including enhanced functionality, improved patient […]
